Showing results (71-80 of 104) with videos related to
Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|March 19, 2020
Cetuximab and Radiation Therapy Versus Cisplatin and Radiation Therapy for Locally Advanced Head and Neck Cancer: Long-Term Survival and Toxicity Outcomes of a Randomized Phase 2 TrialMarta Maddalo, Paolo Borghetti, Davide Tomasini, et al.Cancers|March 13, 2024
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in RhabdomyosarcomaSilvia Codenotti, Leonardo Sandrini, Delia Mandracchia, et al.International Journal of Radiation Oncology, Biology, Physics|December 18, 2016
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck CancerMichela Buglione, Marta Maddalo, Renzo Corvò, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II TrialStefano Maria Magrini, Michela Buglione, Renzo Corvò, et al.British Journal of Cancer|April 28, 2017
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric studyLuca Triggiani, Filippo Alongi, Michela Buglione, et al.Elife|April 24, 2024
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE studyMarco Bergamini, Alberto Dalla Volta, Carlotta Palumbo, et al.Head & Neck|July 30, 2019
Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working groupEster Orlandi, Pierluigi Bonomo, Letizia Ferella, et al.La Radiologia Medica|November 8, 2021
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysisMaurizio Valeriani, Beatrice Detti, Andrei Fodor, et al.La Radiologia Medica|August 19, 2023
Pattern of recurrence after stereotactic body radiotherapy for para-aortic oligo-recurrent prostate cancer, a multicentric analysisGiulio Francolini, Pietro Garlatti, Vanessa Di Cataldo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2023
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO)Giulio Francolini, Andrea Gaetano Allegra, Beatrice Detti, et al.Pageof 11